Mateon Therapeutics Selects IQVIA for its Randomized, Controlled, Multi-Center Clinical Study to Test OT-101 as a Treatment for COVID-19 Patients

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Pat Purcell
Meeting Engagement